SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001826667-24-000034
Filing Date
2024-07-19
Accepted
2024-07-19 16:48:15
Documents
14
Period of Report
2024-07-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A trisalus-2024formproxyx711.htm DEF 14A 1335573
2 a10.jpg GRAPHIC 30672
3 a2.jpg GRAPHIC 30083
4 a3.jpg GRAPHIC 28327
5 a4.jpg GRAPHIC 51001
6 a5.jpg GRAPHIC 32426
7 a6.jpg GRAPHIC 33215
8 a7.jpg GRAPHIC 9078
9 a9.jpg GRAPHIC 27500
10 pic1.jpg GRAPHIC 14281
11 proxycard.jpg GRAPHIC 120049
12 proxycard2.jpg GRAPHIC 85195
13 seanmurphy2.jpg GRAPHIC 42937
14 trisalus_bodheadshotxmarys.jpg GRAPHIC 45770
  Complete submission text file 0001826667-24-000034.txt   2094638
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Filer) CIK: 0001826667 (see all company filings)

IRS No.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39813 | Film No.: 241128274
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)